We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.
Innovation and Technology
9 Jan 2020 - Innovation is considered as a key driver for the future of our business. In 2020 we will highlight our focus and progress on Innovation and Technology […]
Read moreSustainable, cost-efficient manufacturing of therapeutic peptides using chemo-enzymatic peptide synthesis (CEPS)
22 Nov 2019 - Using a large scale biocatalytic manufacture of the antidiabetic exenatide as an example, we report that chemo-enzymatic peptide synthesis (CEPS) constitutes an efficient method for sustainable manufacturing of therapeutic peptides. […]
Read morePolyPeptide News Flash October
24 Oct 2019 - This News Flash features an interview with Olivier Ludemann-Hombourger, Director Global, Technology & Innovation. Find out the latest news in our October Newsletter
Read morePress release: the start of a research collaboration program with IBMM in Montpellier, France
23 Oct 2019 - Mechanochemistry is an emerging technology with unexplored potential. This technology can significantly help with developing greener solutions for the production of synthetic peptides. PolyPeptide Group is […]
Read moreQA interview: Focus innovation
21 Oct 2019 - Interview with Olivier Ludemann-Hombourger, Ph.D. Global Director Innovation & Technology of PolyPeptide Group […]
Read moreReGreen SPPS: enabling circular chemistry in environmentally sensible solid-phase peptide synthesis
15 Oct 2019 - Aiming at greener, scalable methods for cost-efficient peptide synthesis a solid-phase peptide synthesis (SPPS) protocol adhering to the principles of circular chemistry[…]
Read moreEconomic and environmental factors affecting the sustainability of peptide therapeutic manufacturing
14 Sep 2019 - The outlook for peptide therapeutic drugs is bright. The range of medical indications is expanding and the rate at which peptide therapeutic drugs are being approved is increasing.[…]
Read moreA Holistic Quality Control Strategy for Peptide Active Pharmaceutical Ingredients (APIs)
14 Sep 2019 - The goal of consistently achieving critical quality attributes (CQAs) for synthetic peptide active pharmaceutical ingredients (APIs) may be challenging owing to the complexity of the manufacturing process and the large number of potential sources of variability. […]
Read moreSymposium on Preparative and Process Scale HPLC, MCC and SFC 2019
4 Sep 2019 - The PolyPeptide Group will participate in the Symposium on Preparative & Process Scale HPLC, MCC and SFC 2019 on September 10-11 in Gothenburg, Sweden. PolyPeptide Group will […]
Read more